<VariationArchive VariationID="370072" VariationName="NM_000108.5(DLD):c.104dup (p.Tyr35Ter)" VariationType="Duplication" Accession="VCV000370072" Version="29" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-15" DateCreated="2015-07-12" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357557" VariationID="370072">
      <GeneList>
        <Gene Symbol="DLD" FullName="dihydrolipoamide dehydrogenase" GeneID="1738" HGNC_ID="HGNC:2898" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="107891107" stop="107921198" display_start="107891107" display_stop="107921198" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="107531585" stop="107561642" display_start="107531585" display_stop="107561642" Strand="+" />
          </Location>
          <OMIM>238331</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000108.5(DLD):c.104dup (p.Tyr35Ter)</Name>
      <CanonicalSPDI>NC_000007.14:107893263:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="107893263" stop="107893264" display_start="107893263" display_stop="107893264" variantLength="1" positionVCF="107893263" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="107533708" stop="107533709" display_start="107533708" display_stop="107533709" variantLength="1" positionVCF="107533708" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y35*</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000108.3" sequenceAccession="NM_000108" sequenceVersion="3" change="c.104dupA">
            <Expression>NM_000108.3:c.104dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000108.4" sequenceAccession="NM_000108" sequenceVersion="4" change="c.104dupA">
            <Expression>NM_000108.4:c.104dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000108.5" sequenceAccession="NM_000108" sequenceVersion="5" change="c.104dupA" MANESelect="true">
            <Expression>NM_000108.5:c.104dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.107533709dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.107533709dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.107893264dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.107893264dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008045.1" sequenceAccession="NG_008045" sequenceVersion="1" change="g.7124dup">
            <Expression>NG_008045.1:g.7124dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000108.5" sequenceAccession="NM_000108" sequenceVersion="5" change="c.104dup" MANESelect="true">
            <Expression>NM_000108.5:c.104dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000099.2" sequenceAccession="NP_000099" sequenceVersion="2" change="p.Tyr35Ter">
            <Expression>NP_000099.2:p.Tyr35Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289750.1" sequenceAccession="NM_001289750" sequenceVersion="1" change="c.-45dup">
            <Expression>NM_001289750.1:c.-45dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289751.1" sequenceAccession="NM_001289751" sequenceVersion="1" change="c.104dup">
            <Expression>NM_001289751.1:c.104dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276680.1" sequenceAccession="NP_001276680" sequenceVersion="1" change="p.Tyr35Ter">
            <Expression>NP_001276680.1:p.Tyr35Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289752.1" sequenceAccession="NM_001289752" sequenceVersion="1" change="c.104dup">
            <Expression>NM_001289752.1:c.104dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276681.1" sequenceAccession="NP_001276681" sequenceVersion="1" change="p.Tyr35Ter">
            <Expression>NP_001276681.1:p.Tyr35Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4434353" DB="ClinGen" />
        <XRef ID="GTR000569424" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000597667" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="238331.0003" DB="OMIM" />
        <XRef Type="rs" ID="753234219" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000108.5(DLD):c.104dup (p.Tyr35Ter) AND Pyruvate dehydrogenase E3 deficiency" Accession="RCV000409901" Version="17">
        <ClassifiedConditionList TraitSetID="3242">
          <ClassifiedCondition DB="MedGen" ID="C5574660">Pyruvate dehydrogenase E3 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-05" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000108.5(DLD):c.104dup (p.Tyr35Ter) AND not provided" Accession="RCV001591045" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-05" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2015-07-12" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10448086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15712224</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23290025</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23995961</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25356417</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8652022</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8968745</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9298831</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9934985</ID>
        </Citation>
        <DescriptionHistory Dated="2020-06-22">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-05">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-01-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-01-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3242" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9028" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DLD DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">E3 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency, lactic acidosis due to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase (E3) Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maple syrup urine disease, type 3</ElementValue>
                <XRef ID="Maple+syrup+urine+disease+type+1B/4456" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase E3 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MAPLE SYRUP URINE DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyruvate dehydrogenase E3 deficiency</ElementValue>
                <XRef ID="MONDO:0009529" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MSUD3</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DLDD</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3263" />
                <XRef ID="3263" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypes of dihydrolipoamide dehydrogenase (DLD) deficiency are an overlapping continuum that ranges from early-onset neurologic manifestations to adult-onset liver involvement and, rarely, a myopathic presentation. Early-onset DLD deficiency typically manifests in infancy as hypotonia with lactic acidosis. Affected infants frequently do not survive their initial metabolic decompensation, or die within the first few years of life during a recurrent metabolic decompensation. Children who live beyond the first two to three years frequently exhibit growth deficiencies and residual neurologic deficits (intellectual disability, spasticity, ataxia, and seizures). In contrast, isolated liver involvement can present as early as the neonatal period and as late as the third decade. Evidence of liver injury/failure is preceded by nausea and emesis and frequently associated with encephalopathy and/or coagulopathy. Acute metabolic episodes are frequently associated with lactate elevations, hyperammonemia, and hepatomegaly. With resolution of the acute episodes affected individuals frequently return to baseline with no residual neurologic deficit or intellectual disability. Liver failure can result in death, even in those with late-onset disease. Individuals with the myopathic presentation may experience muscle cramps, weakness, and an elevated creatine kinase.</Attribute>
                <XRef ID="NBK220444" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25032271</ID>
                <ID Source="BookShelf">NBK220444</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="2394" DB="Orphanet" />
              <XRef ID="765" DB="Orphanet" />
              <XRef ID="C5574660" DB="MedGen" />
              <XRef ID="MONDO:0009529" DB="MONDO" />
              <XRef Type="MIM" ID="246900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32980" SubmissionDate="2015-07-08" DateLastUpdated="2015-07-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="238331.0003_DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY" title="DLD, 1-BP INS, 105A_DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000032980" DateUpdated="2015-07-12" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with dihydrolipoamide dehydrogenase deficiency (DLDD; 246900), who was originally reported by Craigen (1996), Hong et al. (1996) identified compound heterozygosity for 2 mutations in the DLD gene: a 1-bp insertion (105insA) in the last codon of the leader sequence predicted to result in a frameshift and premature termination (Y35X), and an arg495-to-gly (R495G; 238331.0004) substitution (R460G in the processed protein, Odievre et al., 2005). The patient had developmental delay, hypotonia, metabolic acidosis (elevated serum lactate and pyruvate), a history of transient neonatal hypoglycemia, and features of Leigh syndrome; she died at age 28 months. Plasma amino acid analysis in the patient initially showed increased leucine, isoleucine, and valine. Urine organic acid analysis showed mild to moderate increases of lactic, 2-hydroxybutyric, 3-hydroxybutyric, alpha-ketoglutaric, and 3-hydroxyisovaleric acids. She died at age 28 months. Activities of the PDC and E3 in patient lymphocytes were 26% and 2% of control values, respectively, and in patient fibroblasts were 11% and 14%, respectively. KGDC activity in fibroblasts was 20%. Corresponding values in the clinically unaffected parents were about 50% of normal, except for KGDC, which was normal. These findings suggested that a partial reduction in E3 is not rate-limiting for KGDC activity in fibroblasts. Glycine was also not increased in the patient.</Attribute>
              <Citation>
                <ID Source="PubMed">8652022</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8968745</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15712224</ID>
              </Citation>
              <XRef DB="OMIM" ID="246900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated patients of Ashkenazi-Jewish origin with DLDD, Elpeleg et al. (1997) identified the 105insA mutation in the DLD gene. The 2 patients were heterozygotes for the mutation; no other mutation was identified in the coding region. Heterozygosity for the 105insA mutation was also identified in the cDNA of the father and 1 brother of patient 1, and in the mother and 1 sister of patient 2. Because the enzymatic activity of lipoamide dehydrogenase in muscle tissue of both patients was reduced to 8 to 20% of the control mean, Elpeleg et al. (1997) presumed that both patients were compound heterozygotes for this and another unidentified mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">9298831</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <Name>DLD, 1-BP INS, 105A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 105A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="238331.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2645030" SubmissionDate="2020-04-29" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000108.4:c.104dupA|MedGen:CN043137" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001337760" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15712224</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25356417</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23995961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8968745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23290025</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9934985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10448086</ID>
          </Citation>
          <Comment>Variant summary: DLD c.104dupA (p.Tyr35X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.2e-05 in 250616 control chromosomes (gnomAD). c.104dupA has been reported in the literature in individuals (in compound heterozygous state) affected with Dihydrolipoamide Dehydrogenase Deficiency (MSUD Type 3) (Hong_1996, Shaag_1999). These data indicate that the variant may be associated with disease. Biochemical studies report this variant effect results in decreasing normal activity (Hong_1996, Shaag_1999). One ClinVar submitter (evaluation after 2014) cites the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000108.4:c.104dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Maple syrup urine disease, type 3</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN043137" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7346641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354478" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="696|OMIM:246900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194023" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000485108" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000485108 was merged into SCV001194023 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9298831</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8968745</ID>
          </Citation>
          <Comment>NM_000108.3(DLD):c.104dupA(Y35*) is classified as pathogenic in the context of dihydrolipoamide dehydrogenase deficiency. Sources cited for classification include the following: PMID 9298831 and 8968745. Classification of NM_000108.3(DLD):c.104dupA(Y35*) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="TA" referenceAllele="T" start="107533708" stop="107533708" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="246900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2879324" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000108.5:c.104dupA|Maple syrup urine disease type 3" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001464049" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000108.5:c.104dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Maple syrup urine disease type 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3562227" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="GDXSV:316268" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001817321" DateUpdated="2023-11-25" DateCreated="2021-09-08" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 18362926, 25356417, 8968745, 20672374, 9934985, 15712224, 7815230, 23995961, 9298831)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:653266</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000108.3:c.104dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_28_20210831083931</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7849713" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000108.5:c.104dup|OMIM:246900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004193962" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000108.5:c.104dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="246900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2384963" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4730180|MedGen:CN043137" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001219534" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8968745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9934985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8968745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9934985</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr35*) in the DLD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLD are known to be pathogenic (PMID: 8968745, 9934985). This variant is present in population databases (rs753234219, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with dihydrolipoamide dehydrogenase deficiency (PMID: 8968745, 9934985). ClinVar contains an entry for this variant (Variation ID: 370072). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.107533708_107533709insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043137" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7565664" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-10-14">
        <ClinVarSubmissionID localKey="133516|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004042314" DateUpdated="2024-07-15" DateCreated="2023-10-14" Type="SCV" Version="8" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DLD: PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="TA" referenceAllele="T" start="107533708" stop="107533708" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2354478" TraitType="Disease" MappingType="XRef" MappingValue="246900" MappingRef="OMIM">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7849713" TraitType="Disease" MappingType="XRef" MappingValue="246900" MappingRef="OMIM">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2645030" TraitType="Disease" MappingType="Name" MappingValue="Maple syrup urine disease, type 3" MappingRef="Preferred">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2879324" TraitType="Disease" MappingType="Name" MappingValue="Maple syrup urine disease type 3" MappingRef="Preferred">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2384963" TraitType="Disease" MappingType="XRef" MappingValue="CN043137" MappingRef="MedGen">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32980" TraitType="Disease" MappingType="Name" MappingValue="DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7565664" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3562227" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001524431</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

